Effects of ipriflavone on bone remodeling in primary hyperparathyroidism
- 31 October 1992
- journal article
- Published by Elsevier in Bone and Mineral
- Vol. 19, S27-S33
- https://doi.org/10.1016/0169-6009(92)90863-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of ratsCalcified Tissue International, 1992
- Modulation of Osteoclast DifferentiationEndocrine Reviews, 1992
- Effects of ipriflavone and its metabolites on a clonal osteoblastic cell lineJournal of Bone and Mineral Research, 1991
- Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnoverScandinavian Journal of Clinical and Laboratory Investigation, 1991
- Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidismJournal of Endocrinological Investigation, 1989
- Tartrate-resistant acid phosphatase activity in rat osteoblasts and osteocytesCalcified Tissue International, 1988
- The effect of ipriflavone (TC-80) on bone resorption in tissue cultureJournal of Bone and Mineral Research, 1986
- Effect of ipriflavone on glucocorticoid-induced osteoporosis in ratsLife Sciences, 1986
- Effect of ipriflavone on the response of uterus and thyroid to estrogenLife Sciences, 1986
- Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidismClinica Chimica Acta; International Journal of Clinical Chemistry, 1983